688336 三生国健
已收盘 05-29 15:00:01
资讯
新帖
简况
5月29日三生国健涨8.69%,广发医疗保健股票A基金重仓该股
证券之星 · 05-29 16:38
5月29日三生国健涨8.69%,广发医疗保健股票A基金重仓该股
三生国健涨8.69%,中邮证券三周前给出“买入”评级
证券之星 · 05-29 16:38
三生国健涨8.69%,中邮证券三周前给出“买入”评级
每周股票复盘:三生国健(688336)30日跌幅偏离值累计超70%
证券之星 · 05-24
每周股票复盘:三生国健(688336)30日跌幅偏离值累计超70%
股市必读:三生国健(688336)登5月19日交易所龙虎榜
中金财经 · 05-20
股市必读:三生国健(688336)登5月19日交易所龙虎榜
三生国健最新公告:股价严重异常波动经核实无未披露重大事项
证券之星 · 05-19
三生国健最新公告:股价严重异常波动经核实无未披露重大事项
5月19日三生国健(688336)龙虎榜数据
证券之星 · 05-19
5月19日三生国健(688336)龙虎榜数据
股市必读:三生国健一季报 - 第一季度单季净利润同比增长73.00%
证券之星 · 04-27
股市必读:三生国健一季报 - 第一季度单季净利润同比增长73.00%
三生国健(688336)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 04-26
三生国健(688336)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
三生国健(688336)3月31日股东户数1.6万户,较上期增加1.03%
证券之星 · 04-25
三生国健(688336)3月31日股东户数1.6万户,较上期增加1.03%
图解三生国健一季报:第一季度单季净利润同比增长73.00%
证券之星 · 04-25
图解三生国健一季报:第一季度单季净利润同比增长73.00%
每周股票复盘:三生国健(688336)召开2025年年度股东会
证券之星 · 04-19
每周股票复盘:三生国健(688336)召开2025年年度股东会
4月9日三生国健跌5.27%,广发医疗保健股票A基金重仓该股
证券之星 · 04-09
4月9日三生国健跌5.27%,广发医疗保健股票A基金重仓该股
韧性十足!制药板块逆市飘红,场内唯一药ETF(562050)收复半年线!三生国健业绩炸裂,股价狂飙14%创新高
新浪基金 · 04-02
韧性十足!制药板块逆市飘红,场内唯一药ETF(562050)收复半年线!三生国健业绩炸裂,股价狂飙14%创新高
国金证券:给予三生国健买入评级
证券之星 · 04-02
国金证券:给予三生国健买入评级
三生国健发布2025年业绩,营收同比增长252.63%
蓝鲸财经 · 04-01
三生国健发布2025年业绩,营收同比增长252.63%
图解三生国健年报:第四季度单季净利润同比增长430.28%
证券之星 · 03-31
图解三生国健年报:第四季度单季净利润同比增长430.28%
3月30日三生国健涨13.87%,广发医疗保健股票A基金重仓该股
证券之星 · 03-30
3月30日三生国健涨13.87%,广发医疗保健股票A基金重仓该股
3月23日三生国健跌6.38%,广发医疗保健股票A基金重仓该股
证券之星 · 03-23
3月23日三生国健跌6.38%,广发医疗保健股票A基金重仓该股
医药板块震荡走强 三生国健涨超8%
人民财讯 · 03-17
医药板块震荡走强 三生国健涨超8%
每周股票复盘:三生国健(688336)2025年净利增317.09%
证券之星 · 03-01
每周股票复盘:三生国健(688336)2025年净利增317.09%
加载更多
公司概况
公司名称:
三生国健药业(上海)股份有限公司
所属行业:
医药制造业
上市日期:
2020-07-22
主营业务:
三生国健药业(上海)股份有限公司的主营业务是抗体药物的研发、生产和销售。公司的主要产品是益赛普、赛普汀、健尼哌、益赛拓。公司是“免疫与炎症全国重点实验室”依托单位、拥有抗体药物国家工程研究中心、国家企业技术中心、上海市抗体技术创新中心、上海抗体工程技术研究中心等国家级和上海市级高新技术平台,承担过国家重大新药创制、“863”计划、国家发改委及上海市重大项目及各部委课题百余项,多次获得上海市级和浦东新区科学技术奖。
发行价格:
28.18
{"stockData":{"symbol":"688336","market":"SH","secType":"STK","nameCN":"三生国健","latestPrice":64.44,"timestamp":1780038001000,"preClose":59.29,"halted":0,"volume":8100763,"delay":0,"changeRate":0.0869,"floatShares":617000000,"shares":618000000,"eps":4.8124,"marketStatus":"已收盘","change":5.15,"latestTime":"05-29 15:00:01","open":59.3,"high":66.9,"low":58.01,"amount":507000000,"amplitude":0.1499,"askPrice":64.45,"askSize":290,"bidPrice":64.44,"bidSize":81,"shortable":0,"etf":0,"ttmEps":4.8124,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":5,"adr":0,"adjPreClose":59.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780018200000,1780025400000],[1780030800000,1780038000000]],"highLimit":65.22,"lowLimit":53.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":618086503,"isCdr":false,"pbRate":4.62,"roa":"--","peRate":13.390408,"roe":"2.09%","epsLYR":4.7,"committee":0.254526,"marketValue":39829000000,"turnoverRate":0.0131,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-06-01。","afterMarket":{"amount":0,"volume":0,"close":64.44,"buyVolume":0,"sellVolume":0,"time":1780040038866,"indexStatus":"已收盘 05-29 15:30:00","preClose":59.29},"floatMarketCap":39746000000},"requestUrl":"/m/hq/s/688336","defaultTab":"news","newsList":[{"id":"2639628309","title":"5月29日三生国健涨8.69%,广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639628309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639628309?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:38","pubTimestamp":1780043907,"startTime":"0","endTime":"0","summary":"证券之星消息,5月29日三生国健涨8.69%,收盘报64.44元,换手率1.31%,成交量8.1万手,成交额5.07亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共47家,其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为39.07亿元,最新净值1.6933,较上一交易日下跌2.07%,近一年下跌6.26%。广发医疗保健股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639628526","title":"三生国健涨8.69%,中邮证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2639628526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639628526?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:38","pubTimestamp":1780043897,"startTime":"0","endTime":"0","summary":"今日三生国健涨8.69%,收盘报64.44元。2026年5月8日,中邮证券研究员盛丽华,徐智敏发布了对三生国健的研报《授权收入增厚利润,自免管线稳步推进迈入收获期》,该研报对三生国健给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中邮证券的徐智敏、盛丽华。三生国健个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373447","title":"每周股票复盘:三生国健(688336)30日跌幅偏离值累计超70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373447?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:51","pubTimestamp":1779562270,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,三生国健报收于61.8元,较上周的66.58元下跌7.18%。本周,三生国健5月21日盘中最高价报66.69元。本周关注点来自交易信息汇总:三生国健因30个交易日内收盘价跌幅偏离值累计达-70%登上龙虎榜。来自公司公告汇总:三生国健2026年第一季度营收43,123.40万元,同比增长38.61%。来自公司公告汇总:三生国健股票交易连续三十个交易日跌幅偏离值累计超70%,构成严重异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636932938","title":"股市必读:三生国健(688336)登5月19日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2636932938","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636932938?lang=zh_cn&edition=full","pubTime":"2026-05-20 08:17","pubTimestamp":1779236236,"startTime":"0","endTime":"0","summary":"来自龙虎榜上榜:三生国健因连续30个交易日收盘价跌幅偏离值累计达-70%登上龙虎榜。三生国健:股票交易严重异常波动公告三生国健股票交易连续三十个交易日内日收盘价格跌幅偏离值累计超过70%,构成严重异常波动。公司经营正常,研发管线推进顺利,2026年第一季度营收43,123.40万元,同比增长38.61%,净利润17,811.81万元,同比增长73.00%。截至2026年5月19日,公司滚动市盈率为13.45倍,低于行业平均水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260520/32237842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858352","title":"三生国健最新公告:股价严重异常波动经核实无未披露重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636858352?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:50","pubTimestamp":1779187811,"startTime":"0","endTime":"0","summary":"三生国健公告称,公司股票连续三十个交易日内收盘价格跌幅偏离值累计超过70%,属于股票交易严重异常波动情形。经公司自查并向控股股东及实际控制人核实,截至公告披露日,除已披露信息外,公司及控股股东、实控人不存在筹划应披露而未披露的重大事项,公司日常经营情况正常,未发生重大变化,所处行业政策未发生重大调整。公司2026年第一季度实现营业收入4.31亿元,同比增长38.61%,归母净利润1.78亿元,同比增长73.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900035753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636324738","title":"5月19日三生国健(688336)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2636324738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636324738?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:52","pubTimestamp":1779184351,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年5月19日公布的交易公开信息显示,三生国健因有价格涨跌幅限制的连续30个交易日内收盘价格跌幅偏离值累计达到-70%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年5月19日收盘,三生国健报收于64.41元,下跌0.51%,换手率0.75%,成交量4.62万手,成交额2.96亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630335396","title":"股市必读:三生国健一季报 - 第一季度单季净利润同比增长73.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630335396","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630335396?lang=zh_cn&edition=full","pubTime":"2026-04-27 01:30","pubTimestamp":1777224641,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,三生国健报收于77.49元,下跌2.31%,换手率1.04%,成交量6.39万手,成交额4.98亿元。来自业绩披露要点:2026年一季度归母净利润达1.78亿元,同比增长73.0%。来自公司公告汇总:公司于2026年4月24日召开年度股东会,审议通过包括利润分配、董事薪酬、审计机构变更等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700003717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807199","title":"三生国健(688336)2026年一季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807199?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:17","pubTimestamp":1777155461,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期三生国健发布2026年一季报。截至本报告期末,公司营业总收入4.31亿元,同比上升38.61%,归母净利润1.78亿元,同比上升73.0%。本报告期三生国健盈利能力上升,毛利率同比增幅6.35%,净利率同比增幅27.23%。去年的净利率为68.87%,算上全部成本后,公司产品或服务的附加值极高。持有三生国健最多的基金为广发医疗保健股票A,目前规模为39.07亿元,最新净值1.8567,较上一交易日上涨0.34%,近一年上涨3.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630487053","title":"三生国健(688336)3月31日股东户数1.6万户,较上期增加1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630487053","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630487053?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:06","pubTimestamp":1777108014,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三生国健披露,截至2026年3月31日公司股东户数为1.6万户,较2月28日增加163.0户,增幅为1.03%。在生物制品行业个股中,三生国健股东户数低于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.6万户。从股价来看,2026年2月28日至2026年3月31日,三生国健区间涨幅为27.28%,在此期间股东户数增加163.0户,增幅为1.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630824854","title":"图解三生国健一季报:第一季度单季净利润同比增长73.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630824854","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630824854?lang=zh_cn&edition=full","pubTime":"2026-04-25 02:32","pubTimestamp":1777055562,"startTime":"0","endTime":"0","summary":"证券之星消息,三生国健2026年一季报显示,一季度公司主营收入4.31亿元,同比上升38.61%;归母净利润1.78亿元,同比上升73.0%;扣非净利润1.49亿元,同比上升59.29%;负债率4.11%,投资收益283.96万元,财务费用1514.65万元,毛利率80.71%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500007114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628563687","title":"每周股票复盘:三生国健(688336)召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2628563687","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628563687?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:20","pubTimestamp":1776532818,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,三生国健报收于85.76元,较上周的82.2元上涨4.33%。本周,三生国健4月15日盘中最高价报91.44元。三生国健当前最新总市值530.07亿元,在生物制品板块市值排名2/51,在两市A股市值排名383/5198。本周关注点来自公司公告汇总:三生国健于2026年4月24日召开2025年年度股东会,审议多项重要议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626590262","title":"4月9日三生国健跌5.27%,广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626590262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626590262?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:21","pubTimestamp":1775722864,"startTime":"0","endTime":"0","summary":"证券之星消息,4月9日三生国健跌5.27%,收盘报82.1元,换手率2.35%,成交量14.48万手,成交额11.98亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共22家,其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为40.74亿元,最新净值1.9286,较上一交易日上涨0.75%,近一年上涨14.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900025332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624573327","title":"韧性十足!制药板块逆市飘红,场内唯一药ETF(562050)收复半年线!三生国健业绩炸裂,股价狂飙14%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2624573327","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624573327?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:31","pubTimestamp":1775111460,"startTime":"0","endTime":"0","summary":"4月2日午后,A股加速走低,沪指跌逾1%。全市场唯一表征制药板块整体表现的药ETF华宝盘中一度涨超1%,逆市收复半年线! 成份股方面,创新药龙头三生国健绩后狂飙逾14%创历史新高! 整体统计,药ETF华宝已披露2025年全年业绩28家成份股公司中,23家实现盈利,16家净利同比正增长,三生国健、荣昌生物净利增速暂居前二位,分别高达311%、148%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-02/doc-inhtaviy1072263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","01477","BK0239","688336","BK1191","562050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624522314","title":"国金证券:给予三生国健买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624522314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624522314?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:54","pubTimestamp":1775102046,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,唐玉青近期对三生国健进行研究并发布了研究报告《授权收入推动业绩增长,26年管线密集兑现》,给予三生国健买入评级。 风险提示 研发及商业化不及预期风险、大股东持股集中及关联交易风险最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级1家,增持评级1家;过去90天内机构目标均价为72.96。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200016376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624592452","title":"三生国健发布2025年业绩,营收同比增长252.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624592452","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624592452?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:35","pubTimestamp":1775039721,"startTime":"0","endTime":"0","summary":"公司2025年实现营业收入达42.00亿元,同比增长252.63%;归母净利润29.0亿元,同比增幅311.5%;扣非净利润为27.7亿元,同比增长高达1025.0%。2025年毛利率达92.07%,同比提升1.92个百分点;净利率为68.87%,同比大幅提升34.44个百分点。在营收扩张背景下,销售费用同比下降16.33%至1.99亿元,进一步强化了净利率提升效应。研发费用为4.35亿元,同比增长22.00%,占营收比重为10.36%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775034411736558259","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623323046","title":"图解三生国健年报:第四季度单季净利润同比增长430.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623323046","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623323046?lang=zh_cn&edition=full","pubTime":"2026-03-31 02:37","pubTimestamp":1774895866,"startTime":"0","endTime":"0","summary":"证券之星消息,三生国健2025年年报显示,当年度公司主营收入41.99亿元,同比上升251.81%;归母净利润28.99亿元,同比上升311.49%;扣非净利润27.66亿元,同比上升1024.98%;其中2025年第四季度,公司单季度主营收入30.83亿元,同比上升1113.05%;单季度归母净利润25.0亿元,同比上升430.28%;单季度扣非净利润24.14亿元,同比上升8243.6%;负债率6.06%,投资收益7636.32万元,财务费用-4267.45万元,毛利率92.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100005950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623977323","title":"3月30日三生国健涨13.87%,广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623977323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623977323?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:26","pubTimestamp":1774859181,"startTime":"0","endTime":"0","summary":"证券之星消息,3月30日三生国健涨13.87%创60日新高,收盘报81.45元,换手率2.17%,成交量13.39万手,成交额10.61亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共22家,其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为40.74亿元,最新净值1.8152,较上一交易日上涨5.12%,近一年上涨4.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621768027","title":"3月23日三生国健跌6.38%,广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621768027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621768027?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:38","pubTimestamp":1774255110,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日三生国健跌6.38%,收盘报65.56元,换手率1.61%,成交量9.91万手,成交额6.66亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共22家,其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为40.74亿元,最新净值1.7458,较上一交易日下跌1.22%,近一年上涨1.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620541482","title":"医药板块震荡走强 三生国健涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620541482","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620541482?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:36","pubTimestamp":1773714990,"startTime":"0","endTime":"0","summary":"人民财讯3月17日电,医药板块震荡走强,三生国健涨超8%,苑东生物、荣昌生物、海思科、泽璟制药、君实生物等涨幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674269731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","159938","09939","688336","BK1515","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616784356","title":"每周股票复盘:三生国健(688336)2025年净利增317.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616784356","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616784356?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:58","pubTimestamp":1772301489,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,三生国健报收于59.38元,较上周的58.8元上涨0.99%。本周关注点来自业绩披露要点:三生国健2025年归母净利润同比增长317.09%。其一致行动人合计持股比例由84.96%减少至83.83%。三生国健股东达佳国际(香港)有限公司于2025年12月19日至2026年2月27日期间减持公司股份5,894,823股,占总股本0.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780111835116,"stockEarnings":[{"period":"1week","weight":0.0427},{"period":"1month","weight":-0.1193},{"period":"3month","weight":0.0852},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.0637},{"period":"ytd","weight":0.0818}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0227},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2096},{"period":"ytd","weight":0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"三生国健药业(上海)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15976人(较上一季度增加1.03%)","perCapita":"38607股","listingDate":"2020-07-22","address":"上海市浦东新区中国(上海)自由贸易试验区李冰路399号","registeredCapital":"61808万元","survey":" 三生国健药业(上海)股份有限公司的主营业务是抗体药物的研发、生产和销售。公司的主要产品是益赛普、赛普汀、健尼哌、益赛拓。公司是“免疫与炎症全国重点实验室”依托单位、拥有抗体药物国家工程研究中心、国家企业技术中心、上海市抗体技术创新中心、上海抗体工程技术研究中心等国家级和上海市级高新技术平台,承担过国家重大新药创制、“863”计划、国家发改委及上海市重大项目及各部委课题百余项,多次获得上海市级和浦东新区科学技术奖。","listedPrice":28.18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生国健(688336)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生国健(688336)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生国健,688336,三生国健股票,三生国健股票老虎,三生国健股票老虎国际,三生国健行情,三生国健股票行情,三生国健股价,三生国健股市,三生国健股票价格,三生国健股票交易,三生国健股票购买,三生国健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生国健(688336)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生国健(688336)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}